Needham & Company
Serge Belanger is a Managing Director in BioPharma Equity Research. With a background in Senior Research Analyst roles in biopharma, healthcare analysis, and equity research, Serge has also worked as a Senior Research Scientist in R&D and as a Product Manager intern. Serge holds an MBA in Finance/Strategy from NYU Stern School of Business and BSc and MSc degrees in Biochemistry, Pharmacology, and Therapeutics from McGill University.
Needham & Company
1 followers
Needham Capital Partners is a private growth equity firm that invests primarily in the technology and biotech/life-sciences industries. NCP is affiliated with Needham Asset Management, which manages over $600 million in funds for public and private equity investment.